Connect for Cancer Prevention Study (Connect)

Last updated: March 28, 2025
Sponsor: National Cancer Institute (NCI)
Overall Status: Active - Recruiting

Phase

N/A

Condition

Cancer

Treatment

N/A

Clinical Study ID

NCT04609072
10000034
000034-C
  • Ages 30-70
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

Background:

The National Cancer Institute, part of the National Institutes of Health, has partnered with nine health care systems across the U.S. to establish the Connect for Cancer Prevention Study. While researchers have made important discoveries, there is more to learn to lower the number of people affected by cancer. By taking part in Connect, participants can help researchers learn how the way we live, our genetics, and our health history may affect cancer risk.

Objective:

To study and better understand the causes of cancer and to find new ways to prevent it.

Eligibility:

The study will include 200,000 adults who get their health care from a partner health care system, are between 30 and 70 years old at enrollment, and have never had cancer. People remain eligible to join if they have or once had non-melanoma skin cancer, or a condition that may raise cancer risk (such as ductal carcinoma in situ, or DCIS).

Design:

Eligible recruits can sign up for Connect online by creating an account on MyConnect using their email address or phone number. After creating an account, they will complete the informed consent process. All information shared through MyConnect is secure to protect participant privacy. After joining the study, participants will be asked to answer online health surveys a few times a year, donate samples of blood, urine, and saliva every two to three years, and safely share access to their electronic health records with Connect. In the future, participants may donate unused samples that are collected at clinical visits, like tissue, stool, or blood, and may mail in samples collected at home. Participants may also share information from personal health trackers, like wearable devices or apps.

This information will help researchers study the health and behavior patterns that may affect cancer risk.

It takes time to understand the causes of cancer, so Connect will go on for many years. The longer people participate, the more researchers may learn. Participants can leave the study at any time.

Learn more about Connect by visiting cancer.gov/connectstudy.

Eligibility Criteria

Inclusion

  • INCLUSION CRITERIA:

Due to the minimal risk nature of this protocol, all individuals interested and able to participate in Connect for Cancer Prevention, who meet the eligibility criteria and are not specifically excluded, will be able to participate. In order to be eligible to participate in this study, an individual must meet all of the following criteria:

  • Patients or members of participating IHCS at the time of enrollment

  • Age between 30 and 70 years old at study invitation

If an individual is determined to be ineligible at the time of enrollment due to age, the individual will be allowed to re-enroll at a later time once the recruit meets the age requirement.

Exclusion

EXCLUSION CRITERIA:

An individual who meets any of the following criteria will be excluded from participation in this study:

  • Individuals with a history of invasive cancer (other than non-melanoma skin cancer)

  • Individuals with known cognitive impairment documented in their medical record

Study Design

Total Participants: 200000
Study Start date:
July 26, 2021
Estimated Completion Date:
December 31, 2070

Study Description

Study Description:

Connect is an observational cohort study that will prospectively collect exposure information and biospecimens and follow participants for cancer and other endpoints. Participants will be free of cancer at study invitation. Because most cancers develop over long periods of time and biological, behavioral and environmental factors can influence cancer development and change over time, participants will be asked to provide repeated exposure information and biological specimens. The study protocol takes advantage of developments in digital technologies as well as exposure and biomarker assessment tools to investigate suspected and emerging factors that can influence cancer development. The study data system will be built within an efficient, flexible and integrated cloud-hosted infrastructure that leverages modern interoperability standards in order to be an accessible research resource for current and future generations of scientists.

Objectives:

The primary objective is to build a state-of-the-art cohort in the US using new technologies and methods to provide a diverse and comprehensive research resource for the scientific community to study:

cancer etiology

precursor to tumor transformation

cancer risk assessment

early detection of cancer

second cancer development and survivorship after a cancer diagnosis

The secondary objective is to establish a rich database connected to a biorepository for general research use.

Endpoints:

The primary endpoints are the continuum of cancer incidence, detection, progression, and survival. Secondary endpoints are numerous and could include methodological research, human biology, ancestry, evolution or health-related outcomes.

Connect with a study center

  • Kaiser Permanente Colorado

    Denver, Colorado 80247
    United States

    Active - Recruiting

  • Kaiser Permanente Georgia

    Atlanta, Georgia 30305
    United States

    Active - Recruiting

  • Kaiser Permanente Hawaii

    Honolulu, Hawaii 96814
    United States

    Active - Recruiting

  • NORC at the University of Chicago

    Chicago, Illinois 60603
    United States

    Active - Recruiting

  • University of Chicago Medical Center

    Chicago, Illinois 60603
    United States

    Active - Recruiting

  • National Cancer Institute (NCI)- DCEG

    Bethesda, Maryland 20892
    United States

    Site Not Available

  • Henry Ford Health Systems

    Detroit, Michigan 48202
    United States

    Active - Recruiting

  • HealthPartners

    Minneapolis, Minnesota 55425
    United States

    Active - Recruiting

  • Kaiser Permanente Northwest

    Portland, Oregon 97086
    United States

    Active - Recruiting

  • Sanford Health

    Sioux Falls, South Dakota 57117
    United States

    Active - Recruiting

  • Marshfield Clinic Health System

    Marshfield, Wisconsin 54449
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.